Table 2.
COVID-19 event rates and estimated vaccine effectiveness 28 days after vaccination in sub-cohorts compared with the unvaccinated individuals
COVID-19-related hospital admission |
COVID-19-related hospital admission requiring critical or intensive care |
COVID-19-related death |
|||||||
---|---|---|---|---|---|---|---|---|---|
Vaccinated (events/person-years) | Unvaccinated (events/person-years) | Vaccine effectiveness (95% CI) | Vaccinated (events/person-years) | Unvaccinated (events/person-years) | Vaccine effectiveness (95% CI) | Vaccinated (events/person-years) | Unvaccinated (events/person-years) | Vaccine effectiveness (95% CI) | |
Scheme A plus B | 302/43 770 | 897/43 452 | 67% (62–71) | 63/43 794 | 256/43 510 | 75% (69–82) | 28/43 802 | 163/43 527 | 83% (75–89) |
Scheme A | 153/20 128 | 444/19 773 | 66% (60–72) | 19/20 143 | 110/19 802 | 83% (73–90) | 11/20 145 | 75/19 807 | 85% (75–93) |
Scheme B | 149/23 462 | 453/23 679 | 67% (60–73) | 44/23 651 | 146/23 708 | 70% (59–79) | 17/23 657 | 88/23 720 | 80% (69–90) |
Western Cape* | 12/2654 | 39/2651 | 68% (48–86) | .. | .. | .. | .. | .. | .. |
Data on admissions requiring critical or intensive care were not available and too few events occurred to enable analysis of COVID-19-related deaths.